Skip to main content

Table 4 Management and outcome

From: The Acute Chest Syndrome in Cameroonian children living with sickle cell disease

 

Number (N = 21)

Percentage (%)

Antibiotherapy

  

Beta-lactam

  

 Ceftriaxone (IV: 50 mg/kg/day)

10

47.6

 Ampicillin (IV: 50 mg/kg/8 h)

11

52.4

 Gentamicin (IV: 3 mg/kg/day)

16

76.2

 Azithromycin (oral: 5-10 mg/kg/day)

21

100

Adjuvant therapy

  

 Tramadol (IV: 1–2 mg/kg/6 h)

9

42.9

 Paracetamol (oral or IV: 15 mg/kg/6 h)

21

100

 Ibuprofen (oral: 10 mg/kg/8 h)

5

23.8

 Hyperhydration (2.5–3 l/m2 BSa)

21

100

Anti-malarial treatment

  

 No

7

33.3

 Yes

14

66.7

Oxygen therapy

  

 No

14

66.7

 Yes

7

33.3

Transfusion

  

 No

7

33.3

 Yes

14

66.7

Death

  

 Yes

1

4.8

 No

20

95.2

Duration of hospitalization

  

  ≤ 5 days

8

38.1

  > 5 days

13

61.9

  1. aBS = Body surface; IV = intravenous